A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä

Features of the fetal gonad in androgen synthesis in the postpubertal testis are preserved in complete androgen insensitivity syndrome due to a novel genetic splice site donor variant in androgen receptor gene intron 1




TekijätKatarzyna Jarzabek, Mariusz Koda, Marcin Chrusciel, Luiza Kanczuga-Koda, Agnieszka Sobczynska-Tomaszewska, Nafis A. Rahman, Slawomir Wolczynski

KustantajaElsevier Ltd

Julkaisuvuosi2019

JournalJournal of Steroid Biochemistry and Molecular Biology

Tietokannassa oleva lehden nimiJournal of Steroid Biochemistry and Molecular Biology

Artikkelin numero105420

Vuosikerta193

ISSN0960-0760

eISSN1879-1220

DOIhttps://doi.org/10.1016/j.jsbmb.2019.105420


Tiivistelmä

Mutations in the X-linked androgen receptor (AR) gene cause complete androgen insensitivity syndrome (CAIS). CAIS may cause congenital sexual development disorder, which frequently develops into testicular tumors. Here, we describe a novel splice-site intron 1 mutation in AR leading to improper splicing and AR protein absence in CAIS gonads. We characterized a patient’s postpubertal gonadal steroidogenic enzyme expression profile. Localization of both CYP11A1 and CYP17A1 enzymes was restricted to both Leydig tumor cells and adjacent to tumor gonadal tissues. Sertoli cells of the CAIS gonad showed abundant HSD17B3 protein, which is an adult Leydig cell marker that enables the conversion of androstenedione to testosterone. Such HSD17B3 expression is typical for fetal-type Sertoli cells in rodents. The postpubertal CAIS gonad of our patient was completely devoid of androgen signaling pathway activity. Plausibly, the postpubertal Leydig cells consisted of two distinct cell populations: postpubertal fetal-type Leydig cells that persisted as androgen-independent cells and immature adult Leydig cells that failed to differentiate. Taken together, in this CAIS postpubertal testis, both Leydig and fetal-type Sertoli cells participated in testosterone production. Our results indicate the importance of molecular analysis as well as the characterization of steroidogenic enzyme profiling in the CAIS patient’s gonad.



Last updated on 2024-26-11 at 11:07